Arvee Laboratories India Ltd vs Resonance Specialities Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 19, 2026

Key Highlights

The Latest Trading Price of Arvee Laboratories (India) Ltd is ₹ 150 as of 18 Mar 15:30 . The P/E Ratio of Arvee Laboratories (India) Ltd changed from 22.8 on March 2021 to 72.8 on March 2025 . This represents a CAGR of 26.14% over 5 yearsThe P/E Ratio of Resonance Specialities Ltd changed from 13.8 on March 2021 to 11.8 on March 2025 . This represents a CAGR of -3.08% over 5 years The Market Cap of Arvee Laboratories (India) Ltd changed from ₹ 61.05 crore on March 2021 to ₹ 156.47 crore on March 2025 . This represents a CAGR of 20.71% over 5 yearsThe Market Cap of Resonance Specialities Ltd changed from ₹ 144.71 crore on March 2021 to ₹ 77.39 crore on March 2025 . This represents a CAGR of -11.77% over 5 years The revenue of Arvee Laboratories (India) Ltd for the Dec '25 is ₹ 9.92 crore as compare to the Sep '25 revenue of ₹ 3.68 crore. This represent the growth of 169.57% The revenue of Resonance Specialities Ltd for the Dec '25 is ₹ 23.29 crore as compare to the Sep '25 revenue of ₹ 21.89 crore. This represent the growth of 6.4% The ebitda of Arvee Laboratories (India) Ltd for the Dec '25 is ₹ 1.76 crore as compare to the Sep '25 ebitda of ₹ 0.36 crore. This represent the growth of 388.89% The ebitda of Resonance Specialities Ltd for the Dec '25 is ₹ 3.77 crore as compare to the Sep '25 ebitda of ₹ 2.72 crore. This represent the growth of 38.6% The net profit of Arvee Laboratories (India) Ltd changed from ₹ 0.94 crore to ₹ 1.83 crore over 7 quarters. This represents a CAGR of 46.33% The net profit of Resonance Specialities Ltd changed from ₹ 0.59 crore to ₹ 2.51 crore over 7 quarters. This represents a CAGR of 128.73% The Dividend Payout of Arvee Laboratories (India) Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Resonance Specialities Ltd changed from 10.97 % on March 2021 to 17.56 % on March 2025 . This represents a CAGR of 9.87% over 5 years .

About Arvee Laboratories (India) Ltd

Arvee Laboratories (India) Limited was incorporated as a Private Limited Company with the name 'Arvee Laboratories (India) Private Limited' on January 27, 2012 in Ahmedabad, Gujarat.
Subsequently, the Company name was changed to Arvee Laboratories (India) Limited upon conversion into a Public Limited Company on September 19, 2017.
Presently, the Company is engaged in manufacturing of specialized chemicals. Initially, the control & management of the Company was with Mr. Bharat Rasiklal Chokshi, Mr Saumil Bharatbhai Chokshi, Mr. Sudhakarbhai Chhotabhai Patel and Mr. Shalin Bharat Chokshi who were the subscribers to the Memorandum of Association.
Since, April 01, 2013 the control & management was completely taken over by Mr. Shalin Sudhakarbhai Patel and Mr. Shalin Bharat Chokshi. The Company started construction of its first plant for Thiophene Derivatives in 2013.

About Resonance Specialities Ltd

Resonance Specialities Limited (Formerly known Armour Polymers Limited) was incorporated in June, 1989 as a Private Limited Company in Maharashtra.
The Company thereafter got converted into a Public Limited Company in March, 1990.
The Company is manufacturing and marketing of Pyridine and Pyridine derivatives, Picoline, Cynopyridine and some bulk drugs. The Company's plant is located in the Tarapur Industrial Zone near Mumbai , India.
It has plants to manufacture Pyridines, Picolines, Lutidines, Collidines, Cyanopyridines and for various value added products.
In Feb.'92, it came out with a public issue to part-finance a project to manufacture 324 tpa of picoline (alpha, beta and gamma) and 346 tpa of pyridine. Pyridines and picolines are widely used in pharmaceuticals, chemicals, dyestuffs and agro chemicals.

FAQs for the comparison of Arvee Laboratories (India) Ltd and Resonance Specialities Ltd

Which company has a larger market capitalization, Arvee Laboratories (India) Ltd or Resonance Specialities Ltd?

Market cap of Arvee Laboratories (India) Ltd is 165 Cr while Market cap of Resonance Specialities Ltd is 103 Cr

What are the key factors driving the stock performance of Arvee Laboratories (India) Ltd and Resonance Specialities Ltd?

The stock performance of Arvee Laboratories (India) Ltd and Resonance Specialities Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Arvee Laboratories (India) Ltd and Resonance Specialities Ltd?

As of March 19, 2026, the Arvee Laboratories (India) Ltd stock price is INR ₹150.0. On the other hand, Resonance Specialities Ltd stock price is INR ₹89.96.

How do dividend payouts of Arvee Laboratories (India) Ltd and Resonance Specialities Ltd compare?

To compare the dividend payouts of Arvee Laboratories (India) Ltd and Resonance Specialities Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.